Einträge von Dhermain, Frederic auf dem Publikationsserver

Le Rhun, Emilie, Devos, Patrick , Winklhofer, Sebastian, Lmalem, Hafida, Brandsma, Dieta, Kumthekar, Priya, Castellano, Antonella , Compter, Annette, Dhermain, Frederic, Franceschi, Enrico, Forsyth, Peter, Furtner, Julia, Galldiks, Norbert, Gállego Pérez-Larraya, Jaime, Gempt, Jens, Hattingen, Elke, Hempel, Johann Martin, Lukacova, Slavka, Minniti, Giuseppe, O’Brien, Barbara, Postma, Tjeerd J, Roth, Patrick , Rudà, Roberta, Schaefer, Niklas , Schmidt, Nils O, Snijders, Tom J, Thust, Steffi , van den Bent, Martin , van der Hoorn, Anouk , Vogin, Guillaume , Smits, Marion , Tonn, Joerg C, Jaeckle, Kurt A, Preusser, Matthias , Glantz, Michael, Wen, Patrick Y, Bendszus, Martin und Weller, Michael (2022) Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort. Neuro-Oncology 24 (10), S. 1726-1735. Volltext nicht vorhanden.

van den Bent, Martin J., Tesileanu, C. Mircea S. , Wick, Wolfgang, Sanson, Marc, Brandes, Alba Ariela, Clement, Paul M., Erridge, Sarah, Vogelbaum, Michael A., Nowak, Anna K. , Baurain, Jean Français, Mason, Warren P., Wheeler, Helen, Chinot, Olivier L., Gill, Sanjeev, Griffin, Matthew, Rogers, Leland, Taal, Walter , Rudà, Roberta, Weller, Michael, McBain, Catherine, Reijneveld, Jaap, Enting, Roelien H., Caparrotti, Francesca, Lesimple, Thierry, Clenton, Susan, Gijtenbeek, Anja, Lim, Elizabeth, Herrlinger, Ulrich, Hau, Peter, Dhermain, Frederic, de Heer, Iris, Aldape, Kenneth, Jenkins, Robert B., Dubbink, Hendrikus Jan, Kros, Johan M., Wesseling, Pieter, Nuyens, Sarah, Golfinopoulos, Vassilis, Gorlia, Thierry, French, Pim und Baumert, Brigitta G. (2021) Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study. The Lancet Oncology 22 (6), S. 813-823. Volltext nicht vorhanden.

van den Bent, Martin J., Baumert, Brigitta, Erridge, Sara C., Vogelbaum, Michael A., Nowak, Anna K. , Sanson, Marc, Brandes, Alba Ariela, Clement, Paul M., Baurain, Jean Francais, Mason, Warren P., Wheeler, Helen, Chinot, Olivier L., Gill, Sanjeev, Griffin, Matthew, Brachman, David G., Taal, Walter, Rudà, Roberta, Weller, Michael, McBain, Catherine, Reijneveld, Jaap, Enting, Roelien H., Weber, Damien C., Lesimple, Thierry, Clenton, Susan, Gijtenbeek, Anja, Pascoe, Sarah, Herrlinger, Ulrich, Hau, Peter, Dhermain, Frederic, van Heuvel, Irene, Stupp, Roger, Aldape, Ken, Jenkins, Robert B., Dubbink, Hendrikus Jan, Dinjens, Winand N. M., Wesseling, Pieter , Nuyens, Sarah, Golfinopoulos, Vassilis, Gorlia, Thierry, Wick, Wolfgang und Kros, Johan M. (2017) Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study. The Lancet 390 (10103), S. 1645-1653. Volltext nicht vorhanden.